Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03LFR
|
||||
Former ID |
DCL000392
|
||||
Drug Name |
SB-756050
|
||||
Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Discontinued in Phase 2 | [548743] | ||
Company |
GlaxoSmithKline
|
||||
Structure |
Download2D MOL |
||||
Target and Pathway | |||||
Target(s) | Bile acid receptor | Target Info | Agonist | [550963] | |
KEGG Pathway | Bile secretion | ||||
Pathway Interaction Database | RXR and RAR heterodimerization with other nuclear receptor | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.